Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DUT | P33316 | 3/20 | 0.59 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.45 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.45 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.45 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.45 |
| ▸ | P2RY14 | Q15391 | 4/20 | 0.43 |
| ▸ | P2RY6 | Q15077 | 7/20 | 0.43 |
| ▸ | P2RY2 | P41231 | 9/20 | 0.42 |
| ▸ | P2RY4 | P51582 | 5/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20668719 | 1.00 | DUT (0.59) | DUTSLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL8434905 | 1.00 | DUT (0.59) | DUTSLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL12570231 | 1.00 | DUT (0.59) | DUTSLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL18561499 | 1.00 | DUT (0.59) | DUTSLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL25399104 | 0.95 | DUT (0.56) | DUTSLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL15810632 | 0.95 | DUT (0.56) | DUTSLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL21082394 | 0.95 | DUT (0.56) | DUTSLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL14853755 | 0.95 | DUT (0.56) | DUTSLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL24487858 | 0.95 | DUT (0.56) | DUTSLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL5709831 | 0.95 | DUT (0.56) | DUTSLC28A1SLC28A2SLC29A1SLC28A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023167382-A1 | N4-ISOBUTYRYLOXYCYTIDINE ANALOG SYNTHESIS AND COMPOSITION FOR TREATING VIRAL INFECTION COMPRISING ANTI-VIRAL USE THEREOF | 동아대학교 산학협력단 | 2023-09-07 | — | — | WO | disclosed |
| EP-1000038-B1 | NOVEL PYRIMIDIN DERIVATIVES | ASTRAZENECA AB (SE) | 2002-11-06 | — | — | EP | disclosed |
| EP-1000038-A1 | NOVEL PYRIMIDIN DERIVATIVES | AstraZeneca UK Limited (GB) | 2000-05-17 | — | — | EP | disclosed |
| EP-0973789-A1 | NOVEL PHOSPHATE COMPOUNDS AND THEIR USE AS MEDICAMENTS | Astra Pharmaceuticals Limited (GB) | 2000-01-26 | — | — | EP | disclosed |
| US-5985849-A | Phosphate compounds and their use as medicaments | ASTRA PHARMACEUTICALS LTD. (GB) | 1999-11-16 | — | — | US | disclosed |
| WO-1999005123-A1 | NOVEL PYRIMIDIN DERIVATIVES | ASTRAZENECA UK LIMITED (GB) | 1999-02-04 | — | — | WO | disclosed |
| WO-1998045309-A1 | NOVEL PHOSPHATE COMPOUNDS AND THEIR USE AS MEDICAMENTS | ASTRA PHARMACEUTICALS LTD. (GB) | 1998-10-15 | — | — | WO | disclosed |